证券代码：603106 证券简称：恒银科技 公告编号：2025-027 恒银金融科技股份有限公司 （一）审议通过《关于与关联方设立合资公司暨关联交易的议案》 关于第四届监事会第六次会议决议的公告 监事会认为：本次关联交易事项遵循自愿、公平合理、协商一致的原则，履 行了必要的审议程序，审议及表决程序符合相关法律、法规及《公司章程》的规 定，不存在损害公司及股东尤其是中小股东和非关联股东利益的情形。因此，同 意公司本次与关联方设立合资公司暨关联交易的事项。 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 恒银金融科技股份有限公司（以下简称"公司"）第四届监事会第六次会议通 知于 2025 年 7 月 18 日以邮件的方式通知全体监事，会议于 2025 年 7 月 25 日在 天津自贸试验区（空港经济区）西八道 30 号恒银金融科技园 A 座五楼会议室以 现场会议的方式召开。本次会议由监事会主席梁晓刚先生召集并主持，会议应出 席监事共 3 名，实际出席监事 3 名。本次监事会会议的召集、召开符合《中华人 民共 ...

证券代码：603106 证券简称：恒银科技 公告编号：2025-026 恒银金融科技股份有限公司 关于第四届董事会第六次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 恒银金融科技股份有限公司（以下简称"公司"）第四届董事会第六次会议通 知于 2025 年 7 月 18 日以邮件的方式通知全体董事，会议于 2025 年 7 月 25 日在 天津自贸试验区（空港经济区）西八道 30 号恒银金融科技园 A 座五楼会议室以 现场和通讯相结合的方式召开。本次会议由董事长江浩然先生召集主持，会议应 到董事 7 名，实到董事 7 名，其中董事江斐然先生，独立董事赵息女士、高立里 先生、黄跃军先生以通讯方式参加，公司监事及高级管理人员列席会议。本次董 事会会议的召集、召开符合《中华人民共和国公司法》和《公司章程》的有关规 定，表决所形成决议合法、有效。 公司董事会审计委员会认为：本次关联交易符合公司经营发展的阶段性需求， 不会对公司财务状况及经营产生不利影响，交易定价遵循了公平、公正、公允的 原则，不 ...

2025年7月，恒银科技对外发布《关于上海证券交易所对公司2024年年度报告的信息披露监管问询函回 复的公告》引发市场广泛关注。这份公告显示，恒银科技2021年投入自有资金购买的信托理财产品，截 至2024年末仍有1.85亿元未能收回，且已出现逾期情况。 《金融时报》记者发现，上市公司理财"踩雷"的问题并不少见，但上市公司对包括信托等理财产品的投 资热情并未明显降温，原因何在？ 应关注信托底层资产 近年来，上市公司对信托理财产品的关注度持续上升。信托产品因其相对较高的预期收益率，成为部分 上市公司优化资金配置的重要工具。根据Wind数据，2024年上市公司购买信托产品的金额合计超过 2400亿元，占上市公司购买各类理财产品总金额的较大比重。 尽管信托产品在收益率上具有一定吸引力，但其非保本的特性使得一旦底层资产出现问题，投资者可能 面临本金损失的风险。近期恒银科技再度因信托理财逾期问题引发市场关注。 据了解，恒银科技此次逾期的信托理财涉及两笔投资。其中，2021年7月购入的国民信托・慧金87号集 合资金信托计划，投入本金1.7亿元，但截至2024年年报披露时，公司仅收到0.13亿元投资收益，剩余本 金及收益均 ...

Core Viewpoint - Hengyin Technology expects a significant turnaround in its financial performance for the first half of 2025, projecting a net profit attributable to shareholders of between 13.5 million and 16.2 million yuan, compared to a loss of 36.65 million yuan in the same period last year [1] Financial Performance - In 2024, Hengyin Technology reported an operating income of 437 million yuan, a year-on-year increase of 2.53% [3] - The net profit attributable to shareholders for 2024 was 40.12 million yuan, representing a year-on-year growth of 119.29% [3] - The non-recurring net profit for 2024 was 10.40 million yuan [3] Reasons for Performance Change - The company has improved its operational governance and steadily advanced cost reduction and efficiency enhancement, leading to a decrease in overall costs compared to the previous year [1] - Hengyin Technology has maintained stable revenue growth while optimizing its product structure to promote high-margin products, thereby increasing the overall gross margin of its products [1] - The company has actively pursued international market expansion, resulting in a significant increase in overseas sales for the first half of 2025 compared to the same period last year [1]

Group 1: Stock Performance - Zhejiang Zhenyuan and Asia-Pacific Pharmaceutical both achieved a 2-day limit-up with increases of 10.01% and 9.98% respectively, driven by innovation in pharmaceuticals [2] - Chengdu XianDao saw a first board listing with a significant rise of 20.02%, attributed to innovative drug developments [2] - TaiJing Technology and YanHua Intelligent both recorded first board listings with increases of 9.97% and 9.94%, linked to Huawei's influence in robotics [5] Group 2: AI and Robotics - Nvidia's CEO suggested that Huawei's AI chips could potentially replace Nvidia's offerings, indicating a competitive shift in the AI chip market [4] - The domestic robotics industry is gaining traction with significant orders being awarded, highlighting its importance in national competition [7] Group 3: Market Trends - The light communication sector is expected to see sustained growth due to high demand in both domestic and international markets, with performance likely to continue improving [13] - The low-altitude economy is gaining attention, with a notable $1 billion procurement agreement signed for eVTOL aircraft, indicating growth potential in this sector [17] Group 4: Consumer and Retail - The Chinese government is implementing measures to boost consumer spending, which is expected to positively impact the retail sector [21] - Companies like Guoguang Chain and Hanshang Group have seen first board listings with increases of 9.98% and 9.97%, reflecting the positive sentiment in the retail market [23] Group 5: Solar and Food & Beverage - The price of polysilicon has increased by 12.4% week-on-week, indicating a rising trend in the solar industry [24] - The food and beverage sector is also benefiting from government initiatives aimed at enhancing consumer demand, with companies like Huangshi Group seeing a 10.10% increase [26]

Group 1 - The core viewpoint of the news highlights a resurgence in the financial technology sector, with the China Securities Financial Technology Theme Index rising over 1% on July 17, driven by strong performance from constituent stocks [1] - Notable stocks such as Hengyin Technology, Tuorisi, and Runhe Software saw significant gains, with Hengyin Technology quickly hitting the upper limit within minutes of market opening [1] - The financial technology ETF (159851) experienced a price increase of over 1%, with trading volume exceeding 200 million yuan, indicating strong investor interest and inflow of capital [1] Group 2 - Hengyin Technology announced a profit forecast for the first half of 2025, expecting a net profit attributable to shareholders of 13.5 million to 16.2 million yuan, marking a turnaround from losses [3] - The report indicates a decrease in overall costs and stable revenue growth, with a significant increase in overseas sales compared to the previous year [3] - A report from CITIC Securities suggests that the legalization of stablecoins in Hong Kong will drive the expansion of the stablecoin industry, benefiting sectors such as RWA issuers, consulting/technical support providers, and cross-border payment companies [3] Group 3 - The financial technology ETF (159851) and its associated funds are recommended for investment, as they cover a wide range of themes including internet brokerage, financial IT, cross-border payments, and AI applications [3] - As of July 11, the financial technology ETF had a scale exceeding 7 billion yuan, with an average daily trading volume of over 550 million yuan in the past six months, showcasing its liquidity and scale advantages [3]

Group 1 - Tiande Yu achieved a net profit of 1.52 billion yuan in the first half of 2025, a year-on-year increase of 50.89% [1] - Tiande Yu's operating income for the same period was 12.08 billion yuan, reflecting a growth of 43.35% year-on-year [1] - Fule New Materials plans to reduce its shareholding by up to 1.33%, amounting to 376.25 million shares, due to personal funding needs [1] - Jindi Co. signed an industrial project investment contract with a total investment of no less than 1.5 billion yuan [1] Group 2 - Tuo Xin Pharmaceutical intends to invest 10 million yuan in Jiangsu Jinsan Biotechnology, acquiring a 1.75% stake [1] - Pinming Technology expects a net profit of 28 million to 34 million yuan for the first half of 2025, a year-on-year increase of 231.79% to 302.89% [4] - Shuanglin Co. anticipates a net profit of 251 million to 310 million yuan, representing a growth of 1% to 25% year-on-year [7] Group 3 - Kangxino received approval for clinical trials of its trivalent poliovirus vaccine [8] - Bailian Co. signed a land storage compensation contract worth approximately 2 billion yuan [9] - Wukuang Development plans to issue short-term financing bonds and medium-term notes totaling up to 2 billion yuan each [10] Group 4 - Hengxin Life intends to invest 10 million yuan in a targeted equity investment [12] - Hengyin Technology expects a net profit of 13.5 million to 16.2 million yuan, marking a turnaround from losses [14] - *ST Jinglun anticipates a net loss of 19 million to 22 million yuan for the first half of 2025 [15] Group 5 - Baiyun Electric won a bid for a State Grid project worth 164 million yuan [16] - Zhejiang Energy completed a power generation of 788.48 billion kWh in the first half of 2025, a year-on-year increase of 4.48% [17] - Sheneng Co. reported a power generation of 259.51 billion kWh, a decrease of 1.7% year-on-year [19] Group 6 - Hengerd signed a strategic cooperation framework agreement with Tiangong International [21] - Baotai's application for the listing of Golimumab injection has been accepted by the FDA [23] - Yishitong received a government subsidy of 2 million yuan [24] Group 7 - Jinggong Steel signed a contract worth approximately 550 million yuan for the Jeddah Stadium project in Saudi Arabia [26] - Zhongwang Software received a government subsidy of 28 million yuan [27] - Rongxin Culture used idle funds of 100 million yuan to purchase financial products [29] Group 8 - Lingxiao Pump Industry invested 80 million yuan in financial products [31] - China Pacific Insurance reported a total original insurance premium income of 282 billion yuan from its subsidiaries [32] - Kema Technology expects a net profit of 165 million to 175 million yuan, a year-on-year increase of 18.59% to 25.77% [32] Group 9 - Qujiang Cultural Tourism anticipates a net loss of approximately 13 million to 16.9 million yuan [32] - Daoshi Technology expects a net profit of 220 million to 238 million yuan, a year-on-year increase of 98.77% to 115.03% [32] - Baicheng Medicine forecasts a net profit decline of 95.53% to 100% [33] Group 10 - Bertley plans to invest 198 million yuan to establish a partnership for investments in emerging fields [34] - China Merchants Highway announced the resignation of its chairman due to reaching retirement age [35] - Overseas Chinese Town A reported a 29% decrease in contract sales amount in June [36]

证券代码：603106 证券简称：恒银科技 公告编号：2025-025 恒银金融科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 本期业绩预告适用于"净利润实现扭亏为盈"的情形。 一、本期业绩预告情况 经财务部门初步核算，预计 2025 年半年度实现归属于母公司所有者的净利 润为 1,350.00 万元到 1,620.00 万元，与上年同期（法定披露数据）相比，将实现 扭亏为盈。 预计 2025 年半年度实现归属于母公司所有者的扣除非经常性损益后的净利 润为 1,100.00 万元到 1,320.00 万元。 公司 2025 年半年度预计实现归属于母公司所有者的净利润与上年同期相比 增加，主要原因：一是公司持续提升经营治理水平，稳步推进降本增效，总体成 本费用较上年同期进一步下降；二是公司保持总体营收的稳定增长，同时优化产 品结构，引导高毛利产品的销售，提升公司产品的综合毛利率；三是公司持续推 进国际化战略部署，积极开拓国际市场，提升海外业务规模，2025 年半年度海 外业务销售额较上年同期 ...

证券代码：603106 证券简称：恒银科技 公告编号：2025-025 恒银金融科技股份有限公司 2025 年半年度业绩预盈公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2025 年 1 月 1 日至 2025 年 6 月 30 日。 （二）业绩预告情况 经财务部门初步核算，预计 2025 年半年度实现归属于母公司所有者的净利 润为 1,350.00 万元到 1,620.00 万元，与上年同期（法定披露数据）相比，将实现 扭亏为盈。 预计 2025 年半年度实现归属于母公司所有者的扣除非经常性损益后的净利 润为 1,100.00 万元到 1,320.00 万元。 （三）本期业绩预告情况未经注册会计师审计，但已与会计师进行了充分沟 通。 二、上年同期业绩情况 （一）利润总额：-4,495.30 万元。归属于母公司所有者的净利润为-3,665.41 万元。归属于母公司所有者的扣除非经常性损益的净利润为-4,215.88 万元。 （二）每股收益：-0.0704 元。 重要内容提示： 一、本期业绩预告情况 （一）业绩预告期间 ...

Core Viewpoint - Hengyin Technology (603106.SH) expects to achieve a net profit attributable to shareholders of the parent company between 13.5 million and 16.2 million yuan for the first half of 2025, marking a turnaround from losses in the previous year [1] Group 1: Financial Performance - The anticipated net profit represents a significant improvement compared to the previous year, indicating a successful recovery [1] - The company attributes the performance growth to enhanced operational management, cost reduction, and efficiency improvements [1] Group 2: Strategic Initiatives - Hengyin Technology has optimized its product structure, focusing on increasing sales of high-margin products, which has contributed to an improved overall gross margin [1] - The company is actively pursuing an internationalization strategy, resulting in a substantial increase in overseas sales [1]